Quality of life in patients with thalassemia major referred to Ardabil Buali Hospital in 2012-13
|
Majid Vafaei1 , Maboud Azad 2, Pejhman Shiargar3 , Behzad Kazemi Haki4 |
1- Department of Hematology and Oncology, Ardabil University of Medical Sciences, Ardabil, Iran 2- BS in Laboratory Sciences, Ardabil University of Medical Sciences, Ardabil. Iran , mabodazad@gmail.com 3- General Practitioner, Ardabil University of Medical Sciences, Ardabil. Iran 4- BS in Anesthesiology, urmia University of Medical Sciences, urmia, Iran |
|
Abstract: (6956 Views) |
Background: Beta thalassemia is a common genetic disease in humans. This study aimed to assess various aspects of quality of life in patients with thalassemia major referred to Buali hospital in 2012-13.
Materials and methods: This cross-sectional analytical study was conducted on 40 patients with thalassemia major. Data were analyzed by statistical software SPSS V16 using Chi-square and t-test. The significance level was set at less than 0.05.
Results: 40 patients with mean (± standard deviation) age of 20.38±7.13 years were studied. 50% of patients were in the age range of 30-21 years. 22 patients (55%) were male. The mean age of the diagnosis was 7.5±1.4 months. Mean age of starting deferoxamine was 5.93±4.37 years. Data analysis revealed no significant relationship between age (P=0.246), gender (P= 0.259) and location of residency (P = 0.753) with quality of life.
Conclusion: There were the highest quality within the role of the physical evidence and lowest quality in the area of patient's general health. Quality of caring was appropriate.
Keywords: Beta-thalassemia major, Care, Quality of life, Bu Ali Hospital. |
|
Keywords: Beta-thalassemia major, Care, Quality of life, Bu Ali Hospital |
|
Full-Text [PDF 201 kb]
(3420 Downloads)
|
Semi-pilot: Survey/Cross Sectional/Descriptive |
Subject:
Oncology Received: 2015/02/28 | Accepted: 2015/08/5 | Published: 2015/12/20
|
|
|
|